AF
MRNA icon

Advisornet Financial’s Moderna MRNA Stock Holding History

Advisornet Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37K Sell
91
-7
-7% -$362 ﹤0.01% 1711
2026
Q1 		$4.98K Buy
+98
New +$4.57K ﹤0.01% 1731
2025
Q4 		– Sell
-91
Closed -$2.35K – 2319
2025
Q3 		$2.35K Sell
91
-276
-75% -$7.7K ﹤0.01% 1836
2025
Q2 		$10.1K Buy
367
+225
+158% +$5.92K ﹤0.01% 1476
2025
Q1 		$4.03K Buy
142
+138
+3,450% +$4.9K ﹤0.01% 1652
2024
Q4 		$172 Sell
4
-14
-78% -$669 ﹤0.01% 1895
2024
Q3 		$1.21K Sell
18
-58
-76% -$5.33K ﹤0.01% 1889
2024
Q2 		$9.04K Sell
76
-5
-6% -$633 ﹤0.01% 1343
2024
Q1 		$8.65K Sell
81
-665
-89% -$67K ﹤0.01% 1329
2023
Q4 		$74.2K Sell
746
-1,012
-58% -$85.1K 0.01% 714
2023
Q3 		$182K Sell
1,758
-231
-12% -$25.8K 0.02% 471
2023
Q2 		$242K Sell
1,989
-280
-12% -$37.4K 0.02% 446
2023
Q1 		$348K Sell
2,269
-13
-0.6% -$2.15K 0.03% 360
2022
Q4 		$410K Sell
2,282
-155
-6% -$25.3K 0.04% 327
2022
Q3 		$288K Buy
2,437
+6
+0.2% +$910 0.03% 423
2022
Q2 		$347K Buy
2,431
+23
+1% +$3.29K 0.03% 385
2022
Q1 		$415K Sell
2,408
-34
-1% -$5.72K 0.03% 402
2021
Q4 		$620K Sell
2,442
-87
-3% -$25.4K 0.04% 356
2021
Q3 		$973K Buy
2,529
+297
+13% +$110K 0.07% 241
2021
Q2 		$524K Sell
2,232
-199
-8% -$35.6K 0.03% 375
2021
Q1 		$318K Buy
2,431
+149
+7% +$21.6K 0.02% 445
2020
Q4 		$238K Sell
2,282
-280
-11% -$28.3K 0.02% 463
2020
Q3 		$181K Buy
2,562
+2,434
+1,902% +$170K 0.02% 514
2020
Q2 		$8K Buy
+128
New +$7.01K ﹤0.01% 1358
2020
Q1 		– Sell
-50
Closed -$1K – 1881
2019
Q4 		$1K Hold
50
– – ﹤0.01% 1760
2019
Q3 		$1K Hold
50
– – ﹤0.01% 1763
2019
Q2 		$1K Buy
+50
New +$1.07K ﹤0.01% 1600

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Advisornet Financial's MRNA Position: Q2 2026 in Review

Advisornet Financial reduced its Moderna (MRNA) stake by 7.1% in Q2 2026, selling an estimated $362 and leaving 91 shares worth $6.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Advisornet Financial first reported a position in MRNA in Q2 2019 and has held it in 27 quarters since. The position peaked at $973K in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Advisornet Financial held 91 shares of Moderna worth $6.37K as of Q2 2026.
  • Advisornet Financial sold 7 Moderna shares in Q2 2026, an estimated $362.
  • Moderna made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1711 holding.
  • Advisornet Financial first reported a position in Moderna in Q2 2019 and has held it in 27 quarters since.
  • Advisornet Financial's Moderna position peaked at $973K in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.